title: Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma.
authors.forename: A
authors.initials: A
authors.lastname: Miki
authors.forename: Y
authors.initials: Y
authors.lastname: Oshima
authors.forename: Y
authors.initials: Y
authors.lastname: Otori
authors.forename: M
authors.initials: M
authors.lastname: Kamei
authors.forename: Y
authors.initials: Y
authors.lastname: Tano
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003131:Combined Modality Therapy; D005260:Female; D015355:Glaucoma, Neovascular / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D017075:Laser Coagulation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D012166:Retinal Hemorrhage / Q000517:prevention & control; D014130:Trabeculectomy / Q000379:methods*; D016896:Treatment Outcome; D014821:Vitrectomy / Q000379:methods*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab